Coya Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
Business Wire•11/08/2026•08:00 ET
0
Whiz Insights
Coya Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, announces its financial results for the quarter ended June 30, 2026 and provides a corporate update.
Get started
Create a free account to read the full story.